This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Derry, W. B. Articles by Jordan, M. A. Search for Related Content PubMed PubMed Citation Articles by Derry, W. B. Articles by Jordan, M. A.

Low Potency of Taxol at Microtubule Minus Ends: Implications for its Antimitotic and Therapeutic Mechanism¹

Department of Molecular, Cellular, and Developmental Biology, University of California Santa Barbara, Santa Barbara, California, 93106

In many cells, low concentrations of Taxol potently block mitosis at the transition from metaphase to anaphase, with no change in microtubule polymer mass and no microtubule bundling. Mitotic block ultimately results in apoptotic cell death and appears to be the most potent antitumor mechanism of Taxol (M. A. Jordan et al., Cancer Res. 56: 816–825, 1996). Mitotic inhibition results, at least in part, from stabilization of growing and shortening dynamics, specifically at the plus ends of microtubules, by the binding of very few Taxol molecules to the microtubule surface (M. A. Jordan et al., Proc. Natl. Acad. Sci. USA, 90: 9552–9556, 1993; W. B. Derry et al., Biochemistry, 34: 2203–2211, 1995). A number of actions of Taxol on mitotic spindle function may be due to its effects on microtubule dynamics at the minus ends of microtubules, effects that previously have not been described. Here, we determined the effects of Taxol on minus ends of purified microtubules at steady state. In contrast to the strong stabilizing effects on plus ends, substoichiometric ratios of Taxol bound to tubulin in microtubules did not affect growing, shortening, or dynamicity at minus ends. Thus, in blocked mitotic cells, Taxol can potently suppress dynamics at plus ends of spindle microtubules, whereas its impotence at minus ends permits continued microtubule depolymerization at the spindle poles. Differential effects of Taxol at opposite microtubule ends may explain Taxol's actions on spindle structure and function and its unique potent antitumor action.

¹ This work was supported by United States Public Health Service Grant CA57291 from the National Cancer Institute (to M. A. J. and L. W.) and the Materials Research Laboratory National Science Foundation Grant DMR-9123048 (to W. B. D. and L. W.).

² To whom requests for reprints should be addressed. Phone: (805) 893-5317; Fax: (805) 893-4724; E-mail: jordan@lifesci.lscf.ucsb.edu.

Received 9/26/97. Accepted 1/16/98.

This article has been cited by other articles:

				Z. Yang, A. E. Kenny, D. A. Brito, and C. L. Rieder Cells satisfy the mitotic checkpoint in Taxol, and do so faster in concentrations that stabilize syntelic attachments J. Cell Biol., September 7, 2009; 186(5): 675 - 684. [Abstract] [Full Text] [PDF]

				A. Ray, T. Okouneva, T. Manna, H. P. Miller, S. Schmid, L. Arthaud, R. Luduena, M. A. Jordan, and L. Wilson Mechanism of Action of the Microtubule-Targeted Antimitotic Depsipeptide Tasidotin (Formerly ILX651) and Its Major Metabolite Tasidotin C-Carboxylate Cancer Res., April 15, 2007; 67(8): 3767 - 3776. [Abstract] [Full Text] [PDF]

				X. Zheng, R. L. Chang, X.-X. Cui, G. E. Avila, V. Hebbar, M. Garzotto, W. J. Shih, Y. Lin, S.-E. Lu, A. B. Rabson, et al. Effects of 12-O-Tetradecanoylphorbol-13-acetate (TPA) in Combination with Paclitaxel (Taxol) on Prostate Cancer LNCaP Cells Cultured In vitro or Grown as Xenograft Tumors in Immunodeficient Mice. Clin. Cancer Res., June 1, 2006; 12(11): 3444 - 3451. [Abstract] [Full Text] [PDF]

				T. Manna, D. Thrower, H. P. Miller, P. Curmi, and L. Wilson Stathmin Strongly Increases the Minus End Catastrophe Frequency and Induces Rapid Treadmilling of Bovine Brain Microtubules at Steady State in Vitro J. Biol. Chem., January 27, 2006; 281(4): 2071 - 2078. [Abstract] [Full Text] [PDF]

				D. Panda, K. Rathinasamy, M. K. Santra, and L. Wilson From the Cover: Kinetic suppression of microtubule dynamic instability by griseofulvin: Implications for its possible use in the treatment of cancer PNAS, July 12, 2005; 102(28): 9878 - 9883. [Abstract] [Full Text] [PDF]

				P. Fanara, S. Turner, R. Busch, S. Killion, M. Awada, H. Turner, A. Mahsut, K. L. LaPrade, J. M. Stark, and M. K. Hellerstein In Vivo Measurement of Microtubule Dynamics Using Stable Isotope Labeling with Heavy Water: EFFECT OF TAXANES J. Biol. Chem., November 26, 2004; 279(48): 49940 - 49947. [Abstract] [Full Text] [PDF]

				J. Kelling, K. Sullivan, L. Wilson, and M. A. Jordan Suppression of Centromere Dynamics by Taxol(R) in Living Osteosarcoma Cells Cancer Res., June 1, 2003; 63(11): 2794 - 2801. [Abstract] [Full Text] [PDF]

				P. Giannakakou, M. Nakano, K. C. Nicolaou, A. O'Brate, J. Yu, M. V. Blagosklonny, U. F. Greber, and T. Fojo Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics PNAS, August 6, 2002; 99(16): 10855 - 10860. [Abstract] [Full Text] [PDF]

				J. R. LaFountain Jr., R. Oldenbourg, R. W. Cole, and C. L. Rieder Microtubule Flux Mediates Poleward Motion of Acentric Chromosome Fragments during Meiosis in Insect Spermatocytes Mol. Biol. Cell, December 1, 2001; 12(12): 4054 - 4065. [Abstract] [Full Text] [PDF]

				I. Karakesisoglou, Y. Yang, and E. Fuchs An Epidermal Plakin That Integrates Actin and Microtubule Networks at Cellular Junctions J. Cell Biol., April 3, 2000; 149(1): 195 - 208. [Abstract] [Full Text] [PDF]

				D. Kandioler-Eckersberger, C. Ludwig, M. Rudas, S. Kappel, E. Janschek, C. Wenzel, H. Schlagbauer-Wadl, M. Mittlböck, M. Gnant, G. Steger, et al. TP53 Mutation and p53 Overexpression for Prediction of Response to Neoadjuvant Treatment in Breast Cancer Patients Clin. Cancer Res., January 1, 2000; 6(1): 50 - 56. [Abstract] [Full Text]

				A.-M. C. Yvon, P. Wadsworth, and M. A. Jordan Taxol Suppresses Dynamics of Individual Microtubules in Living Human Tumor Cells Mol. Biol. Cell, April 1, 1999; 10(4): 947 - 959. [Abstract] [Full Text]